Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
PACIRA RG (NQ: PCRX)
36.40 USD  +0.95 (+2.68%)
Streaming Delayed Price  /  Updated: 12:31 PM EDT, Apr 20, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 354,358
Open 35.30
Bid (Size) 36.35 (400)
Ask (Size) 36.40 (200)
Prev. Close 35.45
Today's Range 35.15 - 36.65
52wk Range 26.95 - 52.48
Shares Outstanding 40,711,707
Dividend Yield N/A
Performance
YTD
-21.38%
-21.38%
1 Month
+21.43%
+21.43%
3 Month
-6.91%
-6.91%
6 Month
+9.97%
+9.97%
1 Year
-19.11%
-19.11%
Top News
More News
Detailed Research: Economic Perspectives on PacWest, HD Supply, Limelight Networks, Clean Harbors, Versartis, and Pacira Pharmaceuticals — What Drives Growth in Today's Competitive Landscape
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of PacWest Bancorp... Read More
from GlobeNewswire News Releases
Markets collapse over impending trade war
The threat of an impending trade war with China sent the markets plummeting to close sharply lower with the Dow crashing 572 points to 23,932. Nasdaq collapsed 161 points to 6915. Read More
category Market News
from MarketMinute.com Market Updates
More News
Read More
Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® as a Nerve Block to Produce Regional Analgesia
from GlobeNewswire News Releases
This Morning's Technical Outlook on Generic Drugs Stocks -- Ironwood Pharma, Pacira Pharma, pSivida, and Tetraphase Pharma
from PR Newswire
Pacira Pharmaceuticals, Upcoming PDUFA Date, Analysts Review and Target, FYE Financials
from ACCESSWIRE
Charting a bullish technical tilt, S&P 500 rattles cage on major resistance
category FDX , INTC , CAT , and 18 more.
from MarketWatch
BRIEF-Pacira Announces FDA Approval Of Supplemental New Drug Application For Exparel As A Nerve Block To Produce Regional Analgesia
category companyNews
from Reuters: Company News
This Biotech Stock Catapulted After Its Pain Drug Trumped A Key Rival
from Investor's Business Daily
Notable Friday Option Activity: PCRX, OSTK, CLVS
category Stocks
from Market News Video
Why SUPERVALU, GOL, and Pacira Pharmaceuticals Jumped Today
category SVU , PCRX , GOL
from Motley Fool
The Week Ahead In Biotech: PDUFA Dates, Clinical Trials And Conferences
category News , RIGL , Biotech , and 14 more.
from Benzinga
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial